Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
17,797
archived clinical trials in
Peripheral Vascular Disease

FEIBA and Use of Blood Products in Cardiac Surgery
Factor VIII Inhibitor Bypass Activity (FEIBA) for the Reduction of Transfusion in Cardiac Surgery: A Randomized Double Blind Placebo Controlled Pilot Trial
Status: Enrolling
Updated:  11/2/2017
Oregon Health and Science University
mi
from
Portland, OR
FEIBA and Use of Blood Products in Cardiac Surgery
Factor VIII Inhibitor Bypass Activity (FEIBA) for the Reduction of Transfusion in Cardiac Surgery: A Randomized Double Blind Placebo Controlled Pilot Trial
Status: Enrolling
Updated: 11/2/2017
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
The Research Center of Southern California (Assessment)
mi
from
Carlsbad, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
The Research Center of Southern California (Assessment)
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neuro-Pain Medical Center (Assessment)
mi
from
Fresno, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neuro-Pain Medical Center (Assessment)
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Westview Clinical Research (Assessment)
mi
from
Placentia, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
NeuroMedical Research Institute (Assessment)
mi
from
Panama City, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
NeuroMedical Research Institute (Assessment)
mi
from
Panama City, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Medsol Clinical Research Center (Assessment)
mi
from
Port Charlotte, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Medsol Clinical Research Center (Assessment)
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neurostudies, Inc. (Assessment)
mi
from
Port Charlotte, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neurostudies, Inc. (Assessment)
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of South Florida (Assessment)
mi
from
Tampa, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of South Florida (Assessment)
mi
from
Tampa, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
OSF Saint Francis Healthcare System (Assessment)
mi
from
Peoria, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
OSF Saint Francis Healthcare System (Assessment)
mi
from
Peoria, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Indiana Medical Research, Elkhart Clinic (Assessment)
mi
from
Elkhart, IN
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Indiana Medical Research, Elkhart Clinic (Assessment)
mi
from
Elkhart, IN
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Kansas Institute of Research (Assessment)
mi
from
Overland Park, KA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Kansas Institute of Research (Assessment)
mi
from
Overland Park, KA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
NeuroMedical Clinic of Central Louisiana (Assessment)
mi
from
Alexandria, LA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
NeuroMedical Clinic of Central Louisiana (Assessment)
mi
from
Alexandria, LA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Neurology and Neuroscience Associates, Inc. (Assessment)
mi
from
Akron, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Neurology and Neuroscience Associates, Inc. (Assessment)
mi
from
Akron, OH
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University Hospital Case Medical Center (Surgical)
mi
from
Cleveland, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University Hospital Case Medical Center (Surgical)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Alabama at Birmingham (Surgical/Assessment)
mi
from
Birmingham, AL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Alabama at Birmingham (Surgical/Assessment)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Xenoscience, Inc. (Assessment)
mi
from
Phoenix, AZ
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Xenoscience, Inc. (Assessment)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Ronald Reagan UCLA Medical Center (Assessment/Surgical)
mi
from
Los Angeles, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Ronald Reagan UCLA Medical Center (Assessment/Surgical)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of California Irvine (Assessment)
mi
from
Orange, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of California Irvine (Assessment)
mi
from
Orange, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Providence Saint John's Health Center (Assessment)
mi
from
Santa Monica, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Providence Saint John's Health Center (Assessment)
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Providence St. John's Health Center (Surgical)
mi
from
Santa Monica, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Providence St. John's Health Center (Surgical)
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Miami Miller School of Medicine (Assessment/Surgical)
mi
from
Miami, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Miami Miller School of Medicine (Assessment/Surgical)
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Grady Memorial Hospital (Assessment)
mi
from
Atlanta, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Grady Memorial Hospital (Assessment)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Center for Advanced Research and Education (Assessment)
mi
from
Gainesville, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Center for Advanced Research and Education (Assessment)
mi
from
Gainesville, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Chicago Medical Center (Assessment)
mi
from
Chicago, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Chicago Medical Center (Assessment)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Chicago Medical Center (Surgical)
mi
from
Chicago, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Chicago Medical Center (Surgical)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Consultants in Neurology, Ltd. (Assessment)
mi
from
Northbrook, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Consultants in Neurology, Ltd. (Assessment)
mi
from
Northbrook, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Kansas Medical Center (Surgical)
mi
from
Kansas City, KA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Kansas Medical Center (Surgical)
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Kentucky Hospital (Surgical)
mi
from
Lexington, KY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Kentucky Hospital (Surgical)
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Louisville Clinical Trials Unit (Assessment)
mi
from
Louisville, KY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Louisville Clinical Trials Unit (Assessment)
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Beth Israel Deaconess Medical Center (Surgical)
mi
from
Boston, MA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Beth Israel Deaconess Medical Center (Surgical)
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Wayne State University (Assessment)
mi
from
Detroit, MI
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Wayne State University (Assessment)
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Henry Ford Health System (Assessment)
mi
from
Detroit, MI
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Henry Ford Health System (Assessment)
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Rutgers New Jersey Medical School (Assessment)
mi
from
Newark, NJ
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Rutgers New Jersey Medical School (Assessment)
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
New York University Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
New York University Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
The Burke Rehabilitation Hospital (Assessment)
mi
from
White Plains, NY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
The Burke Rehabilitation Hospital (Assessment)
mi
from
White Plains, NY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Carolinas Rehabilitation (Assessment)
mi
from
Charlotte, NC
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Carolinas Rehabilitation (Assessment)
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Toledo Medical Center (Assessment)
mi
from
Toledo, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Toledo Medical Center (Assessment)
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Hospital of the University of Pennsylvania (Assessment)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Hospital of the University of Pennsylvania (Assessment)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Pennsylvania Hospital (Surgical)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Pennsylvania Hospital (Surgical)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Thomas Jefferson University Comprehensive Stroke Center (Assessment)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Thomas Jefferson University Comprehensive Stroke Center (Assessment)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Abington Neurological Associates (Assessment)
mi
from
Willow Grove, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Abington Neurological Associates (Assessment)
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Chattanooga Center for Neurologic Research (Assessment)
mi
from
Chattanooga, TN
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Chattanooga Center for Neurologic Research (Assessment)
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Texas Health Science Center at Houston (Assessment/Surgical)
mi
from
Houston, TX
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Texas Health Science Center at Houston (Assessment/Surgical)
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
West Virginia University Hospitals (Assessment)
mi
from
Morgantown, WV
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
West Virginia University Hospitals (Assessment)
mi
from
Morgantown, WV
Click here to add this to my saved trials